Join our Newsletter
Browse by Category
-
Most Read this Week
- Anti-malaria groups warn of growing insecticide resistance
- Global Fund board meets in Geneva
- Theraclone Sciences reports positive phase 1 trial results for influenza A antibody
- Maryland proposes additional pertussis, chicken pox booster requirement
- Montana county fights worst ever pertussis outbreak
Tags
Africa AIDS anthrax Australia California Canada Cancer Centers for Disease Control chicken pox China cholera Dengue fever Detection technology Ebola Emergency preparedness H1N1 H5N1 Haiti hepatits Human papillomavirus immunization India Infectious disease Influenza Malaria Maryland Massachusetts Measles Medical Countermeasures meningitis MRSA Mumps New York Pertussis pneumococcal disease pneumonia polio Preparedness research rotavirus Shingles Tuberculosis vaccine development whooping cough World Health Organization
Author Archives: Mary J. Lewis
NIAID announces research awards to fight emerging infectious diseases
The National Institute of Allergy and Infectious Diseases has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases. Read More »
Progress made on Group B streptococcus vaccine
An early clinical study shows that a vaccine to prevent Group B Streptococcus infection is safe and modestly effective, according to findings presented Oct. 30 at the annual meeting of the Infectious Diseases Society of America. Read More »